Molecular analysis highlights TREM2 as a discriminating biomarker for patients suffering from pancreatic ductal adenocarcinoma. - Papakonstantinou D; Wang H; Bani MA; Mulder K; Dunsmore G; Boilève A; Jules-Clément G; Panunzi L; de Sousa LR; de la Calle Fabregat C; Deloger M; Signolle N; et al. (Cancer treatment and research communications, 2025)